** Life sciences firm Danaher's DHR.N shares rise 2.7% to $190 premarket
** DHR posts Q1 adj. profit of $1.88 per share, beating analysts estimates of $1.64 per share, according to the data compiled by LSEG
** Company posts Q1 revenue of $5.70 billion vs estimates of $5.59 billion
** Company anticipates that Q2 revenue will grow low-single digits year-over-year
** DHR expects annual profit in the range of $7.60 to $7.75 per share vs estimates of $7.68 per share
** Company expects annual revenue to grow 3%
** Company expects incurring incremental tariff costs in 2025 of several hundred millions of dollars
** As of last close, DHR fell 19.4% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.